|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 51
Zeitschriftenartikel
Pott, Christiane 
ORCID: https://orcid.org/0009-0005-9260-8340; Jurinovic, Vindi; Trotman, Judith ORCID: https://orcid.org/0000-0001-8009-4593; Kehden, Britta; Unterhalt, Michael; Herold, Michael ORCID: https://orcid.org/0000-0002-6801-3292; Jagt, Richard van der ORCID: https://orcid.org/0000-0001-5706-0109; Janssens, Ann; Kneba, Michael; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Young, Moya; Schmidt, Christian; Knapp, Andrea; Nielsen, Tina; Brown, Helen ORCID: https://orcid.org/0009-0007-3637-891X; Spielewoy, Nathalie; Harbron, Chris; Bottos, Alessia; Mundt, Kirsten; Marcus, Robert; Hiddemann, Wolfgang und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma. A Prospective Analysis of the Phase III GALLIUM Study.
In: Journal of Clinical Oncology [Forthcoming]
[PDF, 794kB]
ORCID: https://orcid.org/0009-0005-9260-8340; Jurinovic, Vindi; Trotman, Judith ORCID: https://orcid.org/0000-0001-8009-4593; Kehden, Britta; Unterhalt, Michael; Herold, Michael ORCID: https://orcid.org/0000-0002-6801-3292; Jagt, Richard van der ORCID: https://orcid.org/0000-0001-5706-0109; Janssens, Ann; Kneba, Michael; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Young, Moya; Schmidt, Christian; Knapp, Andrea; Nielsen, Tina; Brown, Helen ORCID: https://orcid.org/0009-0007-3637-891X; Spielewoy, Nathalie; Harbron, Chris; Bottos, Alessia; Mundt, Kirsten; Marcus, Robert; Hiddemann, Wolfgang und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma. A Prospective Analysis of the Phase III GALLIUM Study.
In: Journal of Clinical Oncology [Forthcoming]
[PDF, 794kB]
Scheubeck, Gabriel ORCID: https://orcid.org/0009-0004-2546-6154; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Schmidt, Christian; Unterhalt, Michael; Rosenwald, Andreas; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Evangelista, Andrea; Ladetto, Marco; Jerkeman, Mats ORCID: https://orcid.org/0000-0003-4509-6707; Ferrero, Simone ORCID: https://orcid.org/0000-0002-9711-1502; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
In: Leukemia, Bd. 37, Nr. 9: S. 1887-1894
[PDF, 1MB]
ORCID: https://orcid.org/0009-0004-2546-6154; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Schmidt, Christian; Unterhalt, Michael; Rosenwald, Andreas; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Evangelista, Andrea; Ladetto, Marco; Jerkeman, Mats ORCID: https://orcid.org/0000-0003-4509-6707; Ferrero, Simone ORCID: https://orcid.org/0000-0002-9711-1502; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
In: Leukemia, Bd. 37, Nr. 9: S. 1887-1894
[PDF, 1MB]
Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Huettmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.
In: Annals of Hematology, Bd. 102: S. 2791-2801
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Huettmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.
In: Annals of Hematology, Bd. 102: S. 2791-2801
[PDF, 1MB]
Villa, Diego; Hoster, Eva; Hermine, Olivier; Klapper, Wolfram; Szymczyk, Michal; Bosly, Andre; Unterhalt, Michael; Rimsza, Lisa M.; Ramsower, Colleen A.; Freeman, Ciara L.; Scott, David W.; Gerrie, Alina S.; Savage, Kerry J.; Sehn, Laurie H. und Dreyling, Martin
(2022):
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
In: Blood Advances, Bd. 6, Nr. 18: S. 5285-5294
Stathis, Anastasios; Mey, Ulrich; Schar, Sami; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A.; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; Sartori, Giulio; Bertoni, Francesco; Buske, Christian; Zucca, Emanuele und Hiddemann, Wolfgang
(2022):
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
In: Blood Advances, Bd. 6, Nr. 13: S. 3911-3920
Hermine, Olivier ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Hänel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschütz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmüller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael
(2021):
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients. A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
In: HemaSphere, Bd. 5, Nr. 7, e600
Zoellner, Anna-Katharina; Unterhalt, Michael; Stilgenbauer, Stephan; Hübel, Kai; Klapper, Wolfram; Hiddemann, Wolfgang; Dreyling, Martin und Hoster, Eva
(2021):
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
In: The Lancet. Haematology, Bd. 8, Nr. 9, e648-e657
Zoellner, Anna-Katharina; Unterhalt, Michael; Stilgenbauer, Stephan; Huebel, Kai; Thieblemont, Catherine; Metzner, Bernd; Topp, Max; Truemper, Lorenz; Schmidt, Christian; Bouabdallah, Kamal; Krauter, Jürgen; Lenz, Georg; Duerig, Jan; Vergote, Vibeke; Schaefer-Eckart, Kerstin; Andre, Marc; Kluin-Nelemans, Hanneke C.; Hoof, Achiel van; Klapper, Wolfram; Hiddemann, Wolfgang; Dreyling, Martin und Hoster, Eva
(2021):
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label multicentre, randomised, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 9, E648-E657
Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Haenel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschuetz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmueller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael
(2021):
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hamatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
In: Hemasphere, Bd. 5, Nr. 7, e600
Alig, Stefan; Jurinovic, Vindi; Esfahani, Mohammad Shahrokh; Haebe, Sarah; Passerini, Verena; Hellmuth, Johannes C.; Gaitzsch, Erik; Keay, William; Tahiri, Natyra; Zoellner, Anna-Katharina; Rosenwald, Andreas; Klapper, Wolfram; Stein, Harald; Feller, Alfred C.; Ott, German; Staiger, Annette M.; Horn, Heike; Hansmann, Martin-Leo; Pott, Christiane; Unterhalt, Michael; Schmidt, Christian; Dreyling, Martin; Alizadeh, Ash A.; Hiddemann, Wolfgang; Hoster, Eva und Weigert, Oliver
(22. September 2020):
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
In: Blood Advances, Bd. 4, Nr. 18: S. 4451-4462
Kluin-Nelemans, Hanneke C.; Hoster, Eva; Hermine, Olivier; Walewski, Jan; Geisler, Christian H.; Trneny, Marek; Stilgenbauer, Stephan; Kaiser, Florian; Doorduijn, Jeanette K.; Salles, Gilles; Szymczyk, Michal; Tilly, Herve; Ribrag, Vincent; Klapper, Wolfram; Pott, Christiane; Unterhalt, Michael; Dreyling, Martin; Kanz, Lothar; Schmidt, Christian; Feugier, Pierre; Thieblemont, Catherine und Zijlstra, Josee M.
(2020):
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.
In: Journal of Clinical Oncology, Bd. 38, Nr. 3: S. 248-256
Rauert-Wunderlich, Hilka; Mottok, Anja; Scott, David W.; Rimsza, Lisa M.; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Hartmann, Sylvia; Thorns, Christoph; Rymkiewicz, Grzegorz; Holte, Harald; Dreyling, Martin; Hoster, Eva und Rosenwald, Andreas
(Februar 2019):
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
In: British Journal of Haematology, Bd. 184, Nr. 4
Alig, Stefan; Jurinovic, Vindi; Pastore, Alessandro; Haebe, Sarah; Schmidt, Christian; Zoellner, Anna-Katharina; Dreyling, Martin; Unterhalt, Michael; Hoster, Eva; Hiddemann, Wolfgang und Weigert, Oliver
(2019):
Impact of age on clinical risk scores in follicular lymphoma.
In: Blood Advances, Bd. 3, Nr. 7: S. 1033-1038
Alig, Stefan; Jurinovic, Vindi; Pastore, Alessandro; Bararia, Deepak; Häbe, Sarah; Hellmuth, Johannes C.; Kridel, Robert; Gascoyne, Randy; Schmidt, Christian; Zöllner, Anna; Buske, Christian; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang; Hoster, Eva und Weigert, Oliver
(2018):
Impact of age on genetics and treatment efficacy in follicular lymphoma.
In: Haematologica
Jurinovic, Vindi; Metzner, Bernd; Pfreundschuh, Michael; Schmitz, Norbert; Wandt, Hannes; Keller, Ulrich; Dreger, Peter; Dreyling, Martin; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva und Weigert, Oliver
(2018):
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
In: Biology of Blood and Marrow Transplantation
Bräss, Jan; Amler, Susanne; Kreuzer, Karl-Anton; Spiekermann, Karsten; Lindemann, Hans Walter; Lengfelder, Eva; Graeven, Ullrich; Staib, Peter; Ludwig, Wolf-Dieter; Biersack, Harald; Ko, Yon-Dschun; Uppenkamp, Michael J.; Wit, Maike de; Korsten, Stefan; Peceny, Rudolf; Gaska, Tobias; Schiel, Xaver; Behringer, Dirk M.; Kiehl, Michael G.; Zinngrebe, Bettina; Meckenstock, Gerald; Römer, Eva; Medgenberg, Dirk; Spaeth-Schwalbe, Ernst; Massenkeil, Gero; Hindahl, Heidrun; Schwerdtfeger, Rainer; Trenn, Guido; Sauerland, Cristina; Koch, Raphael; Lablans, Martin; Faldum, Andreas; Görlich, Dennis; Bohlander, Stefan K.; Schneider, Stephanie; Dufour, Annika; Buske, Christian; Fiegl, Michael; Subklewe, Marion; Bräss, Birgit; Unterhalt, Michael; Baumgartner, Anja; Wörmann, Bernhard; Beelen, Dietrich und Hiddemann, Wolfgang
(2018):
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.
In: Leukemia, Bd. 32, Nr. 12: S. 2558-2571
Jurinovic, Vindi; Kridel, R.; Staiger, A. M.; Szczepanowski, M.; Horn, Heike; Dreyling, Martin; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Zelenetz, A. D.; Barr, P. M.; Friedberg, J. W.; Ansell, S.; Sehn, L. H.; Connors, J. M.; Gascoyne, R. D.; Hiddemann, Wolfgang; Unterhalt, Michael; Weinstock, D. M. und Weigert, O.
(2016):
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy.
In: Blood, Bd. 128, Nr. 8: S. 1112-1120
Koch, K.; Hoster, Eva; Ziepert, M.; Unterhalt, Michael; Ott, German; Rosenwald, Andreas; Hansmann, Martin-Leo; Bernd, W.; Stein, H.; Pöschel, V.; Dreyling, Martin; Trümper, L.; Löffler, M.; Schmitz, N.; Hiddemann, Wolfgang; Pfreundschuh, M. und Klapper, Wolfram
(2016):
Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL.
In: Annals of Oncology, Bd. 27, Nr. 7: S. 1323-1329
Hermine, Olivier; Hoster, Eva; Walewski, J.; Bosly, A.; Stilgenbauer, S.; Thieblemont, C.; Szymczyk, Michal; Bouabdallah, R.; Kneba, M.; Hallek, M.; Salles, G.; Feugier, P.; Ribrag, Vincent; Birkmann, J.; Forstpointner, R.; Haioun, C.; Hänel, M.; Casasnovas, R. O.; Finke, J.; Peter, N.; Bouabdallah, K.; Sebban, C.; Fischer, T.; Dührsen, U.; Metzner, B.; Maschmeyer, G.; Kanz, L.; Schmidt, C.; Delarue, R.; Brousse, N.; Klapper, Wolfram; Macintyre, E.; Delfau-Larue, M. H.; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2016):
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 388, Nr. 10044: S. 565-575
Hiddemann, Wolfgang; Hoster, Eva; Schmidt, C.; Dreyling, Martin und Unterhalt, Michael
(2016):
Aktuelle Therapiestrategien beim follikulären Lymphom.
In: Internist, Bd. 57, Nr. 3: S. 222-229
Hoster, Eva; Rosenwald, Andreas; Berger, F.; Bernd, Heinz Wolfram; Hartmann, S.; Loddenkemper, Christoph; Barth, Thomas E. F.; Brousse, N.; Pileri, S.; Rymkiewicz, G.; Kodet, Roman; Stilgenbauer, S.; Forstpointner, R.; Thieblemont, C.; Hallek, M.; Coiffier, B.; Vehling-Kaiser, U.; Bouabdallah, R.; Kanz, L.; Pfreundschuh, M.; Schmidt, C.; Ribrag, Vincent; Hiddemann, Wolfgang; Unterhalt, Michael; Kluin-Nelemans, J. C.; Hermine, Olivier; Dreyling, Martin und Klapper, Wolfram
(2016):
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 34, Nr. 12: S. 1386-1394
Leich, E.; Hoster, Eva; Wartenberg, M.; Unterhalt, Michael; Siebert, R.; Koch, K.; Klapper, Wolfram; Engelhard, Marianne; Puppe, B.; Horn, Heike; Staiger, A. M.; Stuhlmann-Laeisz, C.; Bernd, Heinz Wolfram; Feller, A. C.; Hummel, Martina; Lenze, D.; Stein, H.; Hartmann, S.; Hansmann, Martin-Leo; Möller, P.; Hiddemann, Wolfgang; Dreyling, Martin; Ott, German und Rosenwald, Andreas
(2016):
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.
In: Leukemia, Bd. 30, Nr. 4: S. 854-860
Hoster, Eva; Geisler, C. H.; Doorduijn, J.; van der Holt, B.; Walewski, J.; Bloehdorn, J.; Ribrag, Vincent; Salles, G.; Hallek, M.; Pott, Christiane; Szymczyk, Michal; Kolstad, A.; Laurell, A.; Raty, R.; Jerkeman, M.; Van’t Veer, M.; Kluin-Nelemans, J. C.; Klapper, Wolfram; Unterhalt, Michael; Dreyling, Martin und Hermine, Olivier
(2015):
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.
In: Leukemia, Bd. 30, Nr. 6: S. 1428-1430
Wehkamp, Ulrike; Pott, Christiane; Unterhalt, Michael; Koch, Karoline; Weichenthal, Michael; Klapper, Wolfram und Oschlies, Ilske
(2015):
Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
In: American Journal of Surgical Pathology, Bd. 39, Nr. 8: S. 1093-1101
[PDF, 914kB]
Pastore, A.; Jurinovic, Vindi; Kridel, R.; Hoster, Eva; Staiger, A. M.; Szczepanowski, M.; Pott, Christiane; Kopp, N.; Murakami, M.; Horn, Heike; Leich, E.; Moccia, A. A.; Mottok, A.; Sunkavalli, A.; van Hummelen, P.; Ducar, M.; Ennishi, D.; Shulha, H. P.; Hother, C.; Connors, J. M.; Sehn, L. H.; Dreyling, Martin; Neuberg, D.; Moller, P.; Feller, A. C.; Hansmann, Martin-Leo; Stein, H.; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Hiddemann, Wolfgang; Gascoyne, R. D.; Weinstock, D. M. und Weigert, O.
(2015):
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
In: Lancet Oncology, Bd. 16, Nr. 9: S. 1111-1122
Delfau-Larue, M. H.; Klapper, Wolfram; Berger, F.; Jardin, F.; Briere, J.; Salles, G.; Casasnovas, O.; Feugier, P.; Haioun, C.; Ribrag, Vincent; Thieblemont, C.; Unterhalt, Michael; Dreyling, Martin; Macintyre, E.; Pott, Christiane; Hermine, Olivier und Hoster, Eva
(2015):
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
In: Blood, Bd. 126, Nr. 5: S. 604-611
Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Klapper, Wolfram; Vogt, N.; Delfau-Larue, M. H.; Hutter, Grit; Cheah, C.; Chiappella, A.; Cortelazzo, Sergio; Pott, Christiane; Hess, G.; Visco, C.; Vitolo, U.; Klener, P.; Aurer, I.; Unterhalt, Michael; Ribrag, Vincent; Hoster, Eva und Hermine, Olivier
(2013):
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
In: Leukemia & Lymphoma, Bd. 54, Nr. 4: S. 699-707
Kluin-Nelemans, H. C.; Hoster, Eva; Hermine, Olivier; Walewski, J.; Trneny, Marek; Geisler, C. H.; Stilgenbauer, S.; Thieblemont, C.; Vehling-Kaiser, U.; Doorduijn, J. K.; Coiffier, B.; Forstpointner, R.; Tilly, H.; Kanz, L.; Feugier, P.; Szymczyk, Michal; Hallek, M.; Kremers, S.; Lepeu, G.; Sanhes, L.; Zijlstra, J. M.; Bouabdallah, R.; Lugtenburg, P. J.; Macro, M.; Pfreundschuh, M.; Prochazka, V.; Di Raimondo, F.; Ribrag, Vincent; Uppenkamp, M.; Andre, M.; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2012):
Treatment of older patients with mantle-cell lymphoma.
In: New England Journal of Medicine / NEJM, Bd. 367, Nr. 6: S. 520-531
Koch, K.; Hoster, Eva; Unterhalt, Michael; Ott, German; Rosenwald, Andreas; Hansmann, Martin-Leo; Engelhard, Marianne; Hiddemann, Wolfgang und Klapper, Wolfram
(2012):
The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.
In: Human Pathology, Bd. 43, Nr. 12: S. 2274-2281
Schneider, F.; Hoster, Eva; Unterhalt, Michael; Schneider, S.; Dufour, A.; Benthaus, T.; Mellert, G.; Zellmeier, Evelyn; Kakadia, P. M.; Bohlander, Stefan K.; Feuring-Buske, M.; Buske, C.; Braess, J.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang und Spiekermann, Karsten
(2012):
The FLT3ITD level has a high prognostic impact in NPM1 mutated, but not NPM1 unmutated AML with a normal karyotype.
In: Blood, Bd. 119, Nr. 19: S. 4383-4386
Witzens-Harig, Mathias; Hensel, Manfred; Unterhalt, Michael und Herfarth, Klaus
(2011):
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.
In: BMC Cancer
11:87
[PDF, 278kB]
Jin, M. K.; Hoster, Eva; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang und Klapper, Wolfram
(2011):
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
In: Histopathology, Bd. 58, Nr. 4: S. 586-592
Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Hartmann, Elena; Salaverria, Itziar; Hutter, Grit; Perez-Galan, P.; Roue, G.; Pott, Christiane; Le Gouill, Steven; Cortelazzo, Sergio; Rule, S.; Hess, G.; Zaja, F.; Vitolo, U.; Szymczyk, Michal; Walewski, J.; Ribrag, Vincent; Unterhalt, Michael; Hermine, Olivier und Hoster, Eva
(2011):
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
In: Leukemia & Lymphoma, Bd. 52, Nr. 12: S. 2226-2236
Pott, Christiane; Hoster, Eva; Delfau-Larue, M. H.; Beldjord, K.; Böttcher, S.; Asnafi, V.; Plonquet, A.; Siebert, R.; Callet-Bauchu, E.; Andersen, N.; van Dongen, J. J.; Klapper, Wolfram; Berger, F.; Ribrag, Vincent; van Hoof, A. L.; Trneny, Marek; Walewski, J.; Dreger, P.; Unterhalt, Michael; Hiddemann, Wolfgang; Kneba, M.; Kluin-Nelemans, H. C.; Hermine, Olivier; Macintyre, E. und Dreyling, Martin
(2010):
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
In: Blood, Bd. 115, Nr. 16: S. 3215-3223
Klapper, Wolfram; Hoster, Eva; Determann, Olaf; Oschlies, Ilske; Laak, Jeroen van der; Berger, F.; Bernd, Heinz Wolfram; Cabeçadas, José; Campo, Elias; Cogliatti, Sergio; Hansmann, Martin-Leo; Kluin, Philip M.; Kodet, Roman; Krivolapov, Yuri A.; Loddenkemper, Christoph; Stein, H.; Moeller, P.; Barth, Thomas E. F.; Mueller-Hermelink, K.; Rosenwald, Andreas; Pileri, S.; Ralfkiaer, E.; Rymkiewicz, G.; Krieken, Johan H. van; Wacker, Hans Heinrich; Unterhalt, Michael; Hiddemann, Wolfgang und Dreyling, Martin
(2009):
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.
In: Journal of Hematopathology, Bd. 2, Nr. 2: S. 103-111
Herrmann, Annina; Hoster, Eva; Zwingers, T.; Brittinger, G.; Engelhard, Marianne; Meusers, P.; Reiser, M.; Forstpointner, R.; Metzner, B.; Peter, N.; Wörmann, Bernhard; Trümper, L.; Pfreundschuh, M.; Einsele, H.; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2009):
Improvement of overall survival in advanced stage mantle cell lymphoma.
In: Journal of Clinical Oncology, Bd. 27, Nr. 4: S. 511-518
Buske, C.; Hoster, Eva; Dreyling, Martin; Eimermacher, H.; Wandt, H.; Metzner, B.; Fuchs, R.; Bittenbring, J.; Wörmann, Bernhard; Hohloch, K.; Hess, G.; Ludwig, W. D.; Schimke, J.; Schmitz, S.; Kneba, M.; Reiser, M.; Graeven, U.; Klapper, Wolfram; Unterhalt, Michael und Hiddemann, Wolfgang
(2009):
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
In: Leukemia, Bd. 23, Nr. 1: S. 153-161
Schneider, F.; Hoster, Eva; Unterhalt, Michael; Schneider, S.; Dufour, A.; Benthaus, T.; Mellert, G.; Zellmeier, Evelyn; Bohlander, Stefan K.; Feuring-Buske, M.; Buske, C.; Braess, J.; Fritsch, S.; Heinecke, A.; Sauerland, M. C.; Berdel, W. E.; Büchner, T.; Wörmann, Bernhard; Hiddemann, Wolfgang und Spiekermann, Karsten
(2009):
NPM1, but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high risk myelodysplastic syndrome (MDS).
In: Blood, Bd. 113, Nr. 21: S. 5250-5253
Hoster, Eva; Dreyling, Martin und Unterhalt, Michael
(2008):
Response: Statistical power and validation of the MIPI.
In: Blood, Bd. 112, Nr. 6: S. 2583-2584
Hoster, Eva; Dreyling, Martin; Klapper, Wolfram; Gisselbrecht, C.; van Hoof, A.; Kluin-Nelemans, H. C.; Pfreundschuh, M.; Reiser, M.; Metzner, B.; Einsele, H.; Peter, N.; Jung, W.; Wörmann, Bernhard; Ludwig, W. D.; Dührsen, U.; Eimermacher, H.; Wandt, H.; Hasford, Joerg; Hiddemann, Wolfgang und Unterhalt, Michael
(2008):
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma, Erratum.
In: Blood, Bd. 111, Nr. 2: S. 558-565
Böttcher, S.; Ritgen, M.; Buske, S.; Gesk, S.; Klapper, Wolfram; Hoster, Eva; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Siebert, R.; Kneba, M. und Pott, Christiane
(2008):
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
In: Haematologica, Bd. 93, Nr. 4: S. 551-559
Determann, Olaf; Hoster, Eva; Ott, German; Wolfram-Bernd, H.; Loddenkemper, Christoph; Hansmann, Martin-Leo; Barth, Thomas E. F.; Unterhalt, Michael; Hiddemann, Wolfgang; Dreyling, Martin und Klapper, Wolfram
(2008):
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
In: Blood, Bd. 111, Nr. 4: S. 2385-2387
Nickenig, C.; Dreyling, Martin; Hoster, Eva; Ludwig, W. D.; Dörken, B.; Freund, M.; Huber, C.; Ganser, A.; Trümper, L.; Forstpointner, R.; Unterhalt, Michael und Hiddemann, Wolfgang
(2007):
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas: Results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
In: Annals of Oncology, Bd. 18, Nr. 1: S. 136-142
Klapper, Wolfram; Hoster, Eva; Rolver, L.; Schrader, C.; Janssen, D.; Tiemann, M.; Bernd, Heinz Wolfram; Determann, Olaf; Hansmann, Martin-Leo; Möller, P.; Feller, A.; Stein, H.; Wacker, Hans Heinrich; Dreyling, Martin; Unterhalt, Michael; Hiddemann, Wolfgang und Ott, German
(2007):
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
In: Journal of Clinical Oncology, Bd. 25, Nr. 22: S. 3330-3336
Buske, C.; Hoster, Eva; Dreyling, Martin; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2006):
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vinc.
In: Blood, Bd. 108, Nr. 5: S. 1504-1508
Nickenig, C.; Dreyling, Martin; Hoster, Eva; Pfreundschuh, M.; Trumper, L.; Reiser, M.; Wandt, H.; Lengfelder, E.; Unterhalt, Michael und Hiddemann, Wolfgang
(2006):
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
In: Cancer, Bd. 107, Nr. 5: S. 1014-1022
Lenz, G.; Dreyling, Martin; Hoster, Eva; Wörmann, Bernhard; Dührsen, U.; Metzner, B.; Eimermacher, H.; Neubauer, A.; Wandt, H.; Steinhauer, H.; Martin, S.; Heidemann, E.; Aldaoud, A.; Parwaresch, R.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
In: Journal of Clinical Oncology, Bd. 23, Nr. 23: S. 1984-1992
Dreyling, Martin; Lenz, G.; Hoster, Eva; Van-Hoof, A.; Gisselbrecht, C.; Schmits, R.; Metzner, B.; Truemper, L.; Reiser, M.; Steinhauer, H.; Boiron, J. M.; Boogaerts, M. A.; Aldaoud, A.; Silingardi, V.; Kluin-Nelemans, H. C.; Hasford, Joerg; Parwaresch, R.; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.
In: Blood, Bd. 105, Nr. 7: S. 2677-2684
Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Haferlach, T.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2004):
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
In: Journal of Clinical Oncology, Bd. 22, Nr. 24: S. 4926-4933
Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Forstpointner, R.; Wandt, H.; Freund, M.; Hess, G.; Truemper, L.; Diehl, V.; Kropff, M.; Kneba, M.; Schmitz, N.; Metzner, B.; Pfirrmann, Markus; Unterhalt, Michael und Hiddemann, Wolfgang
(2004):
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
In: Blood, Bd. 104, Nr. 9: S. 2667-2674